EndoChoice stock has earned a "strong buy" rating from four analysts, according to a Storm Investor report.
Here are four points:
1. Analysts have set a 12-month consensus target price of $19.67 for the stock.
2. EndoChoice has a 12-month low of $7.37 and a 12-month high of $19.69.
3. The firm has a 50-day moving average of $8.92 and a 200-day moving average of $13.40.
4. The stock's market cap is $205.05 million.